- 活動詳細說明
Pioneering the New Era of Complex Drug Modalities
– Challenges and Opportunities for the Industry –引領複雜藥物模式的新時代
– 產業的挑戰與機會 –Time
時間Events
主題Speakers
主講人12:30-13:00 Registration
報到13:00-13:10 Opening Remarks
開幕致詞13:10-13:40 Challenges and Opportunities in Next-Generation Cell and Gene Therapies
次世代細胞和基因治療的挑戰與機會Dr. Timothy K. Lu,
Co-Founder,
Senti Biosciences, Inc.13:40-14:10 New Era for IT-Based Cell Manufacturing Industry
基於資訊科技的細胞製造產業新時代Dr. Shin Kawamata,
CEO,
Cyto-Facto Inc.14:10-14:40 Ecosystem and Market Potential of Nucleic Acid Industry
核酸產業生態與市場潛力Dr. Herbert Wu,
CEO,
Taiwan Bio-Manufacturing Corp.14:40-15:00 Coffee Break
中場交流15:00-15:30 Progress and the Future Perspectives of Antibody-Drug Conjugates
抗體藥物複合體的進展與未來展望Dr. Feng Tian,
Co-Founder & CEO,
Luxvitae Therapeutics Inc.15:30-16:00 Experience Sharing in the Antibody-Drug Conjugates Industry: Opportunities and Challenges for CDMOs
CDMO在抗體藥物複合體領域的經驗分享：機會與挑戰Dr. Edward Hsieh,
Vice President of RD,
Formosa Laboratories Inc.16:00-18:00 Panel Discussion
座談討論Interactive Insights: Engaging Q&A on Industry Practices
互動式洞察：產業實務問答
➤ 免費參加
➤ 主辦單位保留活動更動之權利
- 相關圖集
-
-
1020_BMCC_引領複雜藥物模式的新時代_EDM.png
-